Trident Lifeline Ltd. (TLL) 52 Week High Streak: Second Straight Session Near Peak

Trident Lifeline Ltd. has now traded within 2% of its 52-week high for its second straight session, with the stock moving up 10.21% across the streak. The latest price of Rs 417.85 sits above the previous close of Rs 407.70, while the pattern confirms a repeated near-high move rather than a fresh high by itself. The latest Univest figures confirm the price pattern, but they do not establish a company-specific catalyst for the continued move.

At 28 September 2026 at 9:26 AM IST, Trident Lifeline Ltd. last traded at Rs 417.85 after opening at the same level and touching the day high and day low at Rs 417.85. The company has a market capitalisation of Rs 487.49 crore. For readers, the repeated-high pattern matters more than a single-day move because it shows the stock is staying near its yearly high across sessions, not just printing one isolated price jump.

Trident Lifeline Ltd. 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 417.85
Previous Close	Rs 407.7
Today's Move	+Rs 10.15 (+2.49%)
Open	Rs 417.85
High	Rs 417.85
Low	Rs 417.85
Market Capitalisation	Rs 487.49 crore

Trident Lifeline Ltd. (TLL) traded at Rs 417.85 versus the previous close of Rs 407.7, a rise of 2.49%. The stock opened at Rs 417.85, reached a high of Rs 417.85 and touched a low of Rs 417.85.

Trident Lifeline Ltd. share price today is Rs 417.85, up Rs 10.15 or 2.49% from the previous close of Rs 407.70. The stock opened at Rs 417.85 and traded at the same level through the latest update, so the day range currently sits at Rs 417.85 to Rs 417.85. That makes the day’s reading very compact and keeps the focus on the repeated proximity to the 52-week high rather than on intraday swings.

For Trident Lifeline Ltd. stock news readers, the key point is that the share price is not moving in isolation. It is staying near the yearly high for a second straight session, which means the current Trident Lifeline Ltd. share price update is best read as part of a streak. The market capitalisation of Rs 487.49 crore places the move in a clear company-size context, while the latest price action shows steady trading around the same level as the open and high.

Trident Lifeline Ltd. 52 Week High Streak: Consecutive High Analysis

Trident Lifeline Ltd. 52 Week High Streak now stands at a second straight session, and that is the defining detail for this article. Across those sessions, the stock has gained 10.21%, which is the clearest measure of the full move rather than just the latest update. The streak started on 25 September 2026, and the repeated near-high pattern shows persistence around the one-year high zone without requiring a new high to be printed today.

Trident Lifeline Ltd. Consecutive 52 Week High trading often attracts attention because it places the stock in a narrow band near its peak for more than one session. In this case, the latest rise adds to the earlier breakout move, but the latest Univest data only confirms the price pattern. It does not identify a specific corporate event, announcement or market trigger behind the extended strength. That distinction is important for readers following Trident Lifeline Ltd. New One Year High headlines.

What the Repeated 52-Week Highs Show

The repeated 52 Week High Streak suggests that Trident Lifeline Ltd. has stayed near its 52-week peak for long enough to merit a separate read from a one-day breakout. Trident Lifeline Ltd. Back To Back 52 Week Highs are not the same as a fresh one-day high story, because the pattern here is about consistency across sessions and the cumulative move across the streak. That is why the 10.21% streak gain matters more than a single print.

For investors scanning Stocks At One Year High Today or Stocks Hitting 52 Week Highs, the useful takeaway is narrower: the stock continues to trade in the yearly-high zone, but the latest numbers do not confirm why. The latest Trident Lifeline Ltd. 52 Week High Streak data shows price persistence, yet it does not establish a company-specific reason for the move. Should investors track Trident Lifeline Ltd. Breakout behaviour? Yes, but only as a price pattern until a clear corporate development appears.

Trident Lifeline Ltd. (TLL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 487.49 crore
P/E Ratio	25.6x
P/B Ratio	4.95x
ROE	18.78%
ROCE	19.17%
EPS	Rs 15.92
Book Value Per Share	Rs 82.4
Dividend Yield	0%

Trident Lifeline Ltd. (TLL) fundamental metrics show P/E 25.6x, P/B 4.95x, ROE 18.78%, ROCE 19.17%. These figures provide context only and are not a buy or sell signal.

Trident Lifeline Ltd. has a market capitalisation of Rs 487.49 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.6x, P/B at 4.95x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.78% and ROCE of 19.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.92, book value per share of Rs 82.4, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.81x, median ROE of 11.43%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	25.6x
Benchmark Median P/E	27.81x
Benchmark Average P/E	41.19x
Benchmark P/E Range	0x to 735.85x
Company P/B Ratio	4.95x
Benchmark Median P/B	2.83x
Company ROE	18.78%
Benchmark Median ROE	11.43%
Company ROCE	19.17%
Benchmark Median ROCE	13.1%
Company Market Capitalisation	Rs 487.49 crore
Benchmark Median Market Cap	Rs 742.9 crore

Trident Lifeline Ltd. (TLL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Trident Lifeline Ltd. (TLL) has a P/E ratio of 25.6x, which is below the benchmark median of 27.81x, a difference of -7.95%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Trident Lifeline Ltd. (TLL) has a ROE of 18.78%, which is above the benchmark median of 11.43%, a difference of +64.3%. Trident Lifeline Ltd. (TLL) has a ROCE of 19.17%, which is above the benchmark median of 13.1%, a difference of +46.34%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Albert David Ltd.	ALBERTDAVD	497.44	22.04	1.17	-0.38	0.83
SMS Lifesciences India Ltd.	HALEOSLABS	453.08	28.67	2.1	10.03	12.6
Medicamen Biotech Ltd.	MEDICAMEQ	432.72	39.96	1.6	3.23	5.77
Jenburkt Pharmaceuticals Ltd.	JENBURPH	418.56	12.75	2.06	18.84	25.34
INFLUX HEALTHTECH LIMITED	INFLUX	651.57	31.72	6.47	20.38	27.22

Trident Lifeline Ltd. (TLL) has a P/E ratio of 25.6x compared with the displayed peer median of 28.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.78% compares with a peer median of 10.03% across the companies shown in the table. ROCE stood at 19.17% versus the displayed peer median of 12.6%, providing a capital-efficiency comparison. Trident Lifeline Ltd. (TLL) has a market capitalisation of Rs 487.49 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Trident Lifeline Ltd.

• Trident Lifeline Ltd. 52 Week High Streak is now in its second straight session, keeping the stock near its one-year high.
• The cumulative move across the streak is 10.21%, which is more relevant than a single-day move for this pattern.
• Trident Lifeline Ltd. Share Price Today is Rs 417.85, above the previous close of Rs 407.70.
• The stock’s P/E of 25.6 and P/B of 4.95 keep Trident Lifeline Ltd. Stock Analysis firmly tied to valuation.
• The Healthcare and Pharmaceuticals & Drugs backdrop gives context for Trident Lifeline Ltd. Company News and market updates.

About Trident Lifeline Ltd.

Trident Lifeline Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company’s latest market capitalisation is Rs 487.49 crore, and the latest ratio set shows ROE of 18.78%, ROCE of 19.17%, EPS of Rs 15.92 and book value of Rs 82.40. In practical terms, that gives readers a compact snapshot of Trident Lifeline Ltd. stock performance and company financials.

For anyone tracking Trident Lifeline Ltd. NSE and Trident Lifeline Ltd. BSE updates, the current market read is straightforward: the stock is trading near its yearly high for a second straight session, while the business metrics remain central to understanding whether that pricing is justified over time. The latest Trident Lifeline Ltd. Stock News angle is therefore a mix of price pattern and fundamentals.

Frequently Asked Questions

What does Trident Lifeline Ltd. 52 Week High Streak mean?

Ans. It means Trident Lifeline Ltd. has traded within 2% of its 52-week high for consecutive sessions. In this case, the streak is for a second straight session, and the cumulative move across it is 10.21%.

Has Trident Lifeline Ltd. made a new 52-week high today?

Ans. No. The latest numbers show Trident Lifeline Ltd. is trading near its 52-week high, but they do not show a fresh high being set today. The article tracks proximity to that peak, not a new record.

What is the latest Trident Lifeline Ltd. share price?

Ans. The latest price is Rs 417.85, compared with the previous close of Rs 407.70. That places Trident Lifeline Ltd. Share Price Today above the prior session’s level while remaining part of the repeated near-high pattern.

How strong is the cumulative move in the streak?

Ans. The cumulative streak move is 10.21%. That figure is important because it captures the full multi-session rise rather than only the latest price change in Trident Lifeline Ltd. Stock Performance.

What valuation multiples are available for Trident Lifeline Ltd.?

Ans. The latest figures show a P/E of 25.6 and a P/B of 4.95. Trident Lifeline Ltd. Fundamental Analysis also includes ROE of 18.78%, ROCE of 19.17%, EPS of Rs 15.92 and book value of Rs 82.40.

How does Trident Lifeline Ltd. compare with industry peers?

Ans. Its P/E is below the industry median of 27.81 and its P/B is above the industry median of 2.83. On returns, Trident Lifeline Ltd. is also above the industry medians for ROE and ROCE in the latest sector snapshot.

What sector does Trident Lifeline Ltd. belong to?

Ans. Trident Lifeline Ltd. belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That is the correct backdrop for reading its share price, valuation and peer comparison.

What should investors monitor next for Trident Lifeline Ltd.?

Ans. Investors should watch whether Trident Lifeline Ltd. keeps trading near the yearly high, how valuation compares with peers, and whether any company-specific development appears. Until then, the latest data confirms the pattern, not the reason.

Track Trident Lifeline Ltd. (TLL) Share Price on Univest

Use Trident Lifeline Ltd. (TLL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.